Cardlytics Historical Financial Ratios
CDLX Stock | USD 9.40 0.63 7.18% |
Cardlytics is presently reporting on over 104 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 3.76 or Days Sales Outstanding of 170 will help investors to properly organize and evaluate Cardlytics financial condition quickly.
Cardlytics |
About Cardlytics Financial Ratios Analysis
CardlyticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Cardlytics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Cardlytics financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Cardlytics history.
Cardlytics Financial Ratios Chart
Cardlytics financial ratios usually calculated using numerical values taken directly from Cardlytics financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Cardlytics. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
At this time, Cardlytics' Intangibles To Total Assets are fairly stable compared to the past year. Current Ratio is likely to rise to 1.56 in 2024, whereas Price To Sales Ratio is likely to drop 1.03 in 2024. Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Cardlytics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Cardlytics sales, a figure that is much harder to manipulate than other Cardlytics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Cardlytics dividend as a percentage of Cardlytics stock price. Cardlytics dividend yield is a measure of Cardlytics stock productivity, which can be interpreted as interest rate earned on an Cardlytics investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Return On Tangible Assets
A profitability metric that measures a company's ability to generate earnings from its tangible assets.Most ratios from Cardlytics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Cardlytics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.At this time, Cardlytics' Intangibles To Total Assets are fairly stable compared to the past year. Current Ratio is likely to rise to 1.56 in 2024, whereas Price To Sales Ratio is likely to drop 1.03 in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 35.46 | 49.38 | 40.01 | 41.07 | Days Of Inventory On Hand | 0.21 | 0.16 | 0.18 | 0.17 |
Cardlytics fundamentals Correlations
Click cells to compare fundamentals
Cardlytics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cardlytics fundamentals Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Price To Sales Ratio | 7.09 | 20.79 | 7.97 | 0.65 | 1.09 | 1.03 | |
Ptb Ratio | 10.42 | 24.72 | 3.08 | 0.91 | 2.49 | 3.76 | |
Days Sales Outstanding | 148.06 | 169.04 | 160.12 | 146.81 | 148.74 | 169.72 | |
Book Value Per Share | 6.03 | 5.78 | 21.45 | 6.33 | 3.69 | 3.88 | |
Free Cash Flow Yield | 2.93E-4 | (0.00456) | (0.024) | (0.35) | (0.0374) | (0.0393) | |
Invested Capital | 2.58E-4 | 1.2 | 0.29 | 1.11 | 1.93 | 2.02 | |
Operating Cash Flow Per Share | 0.48 | (0.28) | (1.2) | (1.61) | (0.00507) | (0.005324) | |
Capex To Depreciation | (2.43) | (0.87) | (0.35) | (0.31) | (0.42) | (0.44) | |
Pb Ratio | 10.42 | 24.72 | 3.08 | 0.91 | 2.49 | 3.76 | |
Ev To Sales | 6.6 | 20.23 | 7.83 | 1.03 | 1.65 | 1.57 | |
Free Cash Flow Per Share | 0.0184 | (0.65) | (1.59) | (2.02) | (0.34) | (0.36) | |
Roic | (0.32) | (0.12) | (0.16) | (0.1) | (0.3) | (0.31) | |
Inventory Turnover | 1.0K | 1.1K | 1.7K | 2.3K | 2.1K | 2.2K | |
Net Income Per Share | (0.75) | (2.15) | (3.99) | (13.92) | (3.69) | (3.88) | |
Days Of Inventory On Hand | 0.36 | 0.32 | 0.21 | 0.16 | 0.18 | 0.17 | |
Payables Turnover | 106.57 | 90.7 | 35.46 | 49.38 | 40.01 | 41.07 | |
Research And Ddevelopement To Revenue | 0.0556 | 0.0938 | 0.14 | 0.18 | 0.17 | 0.096 | |
Capex To Revenue | (0.0524) | (0.0541) | (0.047) | (0.0452) | (0.0401) | (0.0421) | |
Cash Per Share | 4.4 | 10.78 | 7.25 | 3.65 | 2.52 | 3.14 | |
Pocfratio | 130.28 | (511.35) | (55.25) | (3.58) | (1.8K) | (1.7K) | |
Capex To Operating Cash Flow | (0.96) | 1.33 | 0.33 | 0.25 | 66.98 | 70.33 | |
Pfcf Ratio | 3.4K | (219.32) | (41.66) | (2.87) | (26.72) | (25.38) | |
Days Payables Outstanding | 3.43 | 4.02 | 10.29 | 7.39 | 9.12 | 11.21 | |
Income Quality | (0.67) | 0.14 | 0.3 | 0.12 | 0.001373 | 0.001305 | |
Roe | (0.12) | (0.37) | (0.19) | (2.2) | (1.0) | (1.05) | |
Ev To Operating Cash Flow | 121.17 | (497.51) | (54.3) | (5.69) | (2.8K) | (2.6K) | |
Pe Ratio | (84.37) | (66.45) | (16.55) | (0.42) | (2.49) | (2.62) | |
Return On Tangible Assets | (0.0804) | (0.14) | (0.34) | (1.75) | (0.57) | (0.6) | |
Ev To Free Cash Flow | 3.2K | (213.38) | (40.95) | (4.55) | (40.58) | (38.55) | |
Earnings Yield | (0.26) | (0.0119) | (0.015) | (0.0604) | (2.41) | (0.42) | |
Intangibles To Total Assets | 0.013 | 0.0187 | 0.016 | 0.7 | 0.62 | 0.59 | |
Net Debt To E B I T D A | 8.16 | 2.48 | 0.59 | (1.23) | (5.1) | (5.36) | |
Current Ratio | 2.5 | 4.74 | 1.1 | 1.0 | 1.31 | 1.56 | |
Tangible Book Value Per Share | 5.86 | 5.53 | (5.92) | (6.42) | (5.54) | (5.81) | |
Receivables Turnover | 2.49 | 2.47 | 2.16 | 2.28 | 2.45 | 1.9 | |
Graham Number | 10.06 | 16.71 | 43.89 | 44.54 | 17.52 | 20.63 | |
Shareholders Equity Per Share | 6.03 | 5.78 | 21.45 | 6.33 | 3.69 | 3.88 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cardlytics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardlytics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardlytics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardlytics Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Cardlytics Stock analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is Cardlytics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardlytics. If investors know Cardlytics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardlytics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.57) | Earnings Share (4.66) | Revenue Per Share 8.033 | Quarterly Revenue Growth 0.051 | Return On Assets (0.06) |
The market value of Cardlytics is measured differently than its book value, which is the value of Cardlytics that is recorded on the company's balance sheet. Investors also form their own opinion of Cardlytics' value that differs from its market value or its book value, called intrinsic value, which is Cardlytics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardlytics' market value can be influenced by many factors that don't directly affect Cardlytics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardlytics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardlytics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardlytics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.